Anticipation in familial hematologic malignancies

被引:9
|
作者
Tegg, Elizabeth M. [1 ,2 ]
Thomson, Russell J. [1 ]
Stankovich, Jim M. [1 ]
Banks, Annette [1 ]
Marsden, Katherine A. [1 ,2 ]
Lowenthal, Ray M. [1 ,2 ]
Foote, Simon J. [1 ]
Dickinson, Joanne L. [1 ]
机构
[1] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia
[2] Royal Hobart Hosp, Hobart, Tas, Australia
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOPROLIFERATIVE TUMORS; CANCER DATABASE; LYMPHOMA; MYELOMA; RISK; SUSCEPTIBILITY; INSTABILITY; VARIANTS;
D O I
10.1182/blood-2010-07-296475
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a collection of 11 families with >= 2 generations of family members whose condition has been diagnosed as a hematologic malignancy. In 9 of these families there was a significant decrease in age at diagnosis in each subsequent generation (anticipation). The mean age at diagnosis in the first generation was 67.8 years, 57.1 years in the second, and 41.8 years in the third (P < .0002). This was confirmed in both direct parent-offspring pairs with a mean reduction of 19 years in the age at diagnosis (P = .0087) and when the analysis was repeated only including cases of mature B-cell neoplasm (P = .0007). We believe that these families provide further insight into the nature of the underlying genetic mechanism of predisposition in these families. (Blood. 2011; 117(4):1308-1310)
引用
收藏
页码:1308 / 1310
页数:3
相关论文
共 50 条
  • [11] Thioredoxin and Hematologic Malignancies
    An, Ningfei
    Kang, Yubin
    REDOX AND CANCER, PT A, 2014, 122 : 245 - 279
  • [12] Hematologic malignancies in pregnancy
    Hurley, TJ
    McKinnell, JV
    Irani, MS
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2005, 32 (04) : 595 - +
  • [13] Hematologic Malignancies of the Breast
    Alsadi, Alaa
    Murro, Diana
    Martyn, Colin
    Miller, Ira
    Gattuso, Paolo
    LABORATORY INVESTIGATION, 2015, 95 : 33A - 33A
  • [14] Immunotherapy for Hematologic Malignancies
    Craddock, Charles
    Friedberg, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 343 - +
  • [15] Telomerase in hematologic malignancies
    Bruedigam, Claudia
    Lane, Steven W.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (04) : 346 - 353
  • [16] Immunotherapy in hematologic malignancies
    Kansara, R. R.
    Speziali, C.
    CURRENT ONCOLOGY, 2020, 27 : S124 - S131
  • [17] The Microbiota in Hematologic Malignancies
    Yajing Song
    Bryan Himmel
    Lars Öhrmalm
    Peter Gyarmati
    Current Treatment Options in Oncology, 2020, 21
  • [18] Angiogenesis in hematologic malignancies
    Moehler, TM
    Ho, AD
    Goldschmidt, H
    Barlogie, B
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 45 (03) : 227 - 244
  • [19] Hematologic malignancies of childhood
    Head, David R.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 : S7 - S7
  • [20] Epigenetics in the hematologic malignancies
    Fong, Chun Yew
    Morison, Jessica
    Dawson, Mark A.
    HAEMATOLOGICA, 2014, 99 (12) : 1772 - 1783